Atai Therapeutics, Inc.
New York, NY
- UEI
- TE66JYGMACX5
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 250 W 34th St., New York, NY 10119, USA
- Website
- ataibeckley.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Optimization and development of non-hallucinogenic 5-HT2A/2C agonists as opioid use disorder therapeutics - project… | National Institute on Drug Abuse | $5,657,616 |
Quick answers
What is Atai Therapeutics, Inc.'s UEI?
Atai Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is TE66JYGMACX5.
Where is Atai Therapeutics, Inc. located?
Atai Therapeutics, Inc.'s physical address in SAM.gov is 250 W 34th St., New York, NY 10119, USA.
Is Atai Therapeutics, Inc. registered in SAM.gov?
Yes. Atai Therapeutics, Inc.'s SAM.gov registration is active through May 4, 2027.
What is Atai Therapeutics, Inc.'s most recent federal award?
Atai Therapeutics, Inc.'s most recent federal grant award is Optimization and development of non-hallucinogenic 5-HT2A/2C agonists as opioid use disorder therapeutics - project… (UG3DA064403), from National Institute on Drug Abuse, on August 15, 2025.
On GovTribe
See Atai Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors